ocriplasmin Articles

Fujifilm Diosynth to manufacture ocriplasmin for ThromboGenics

20 November 2012

Ph III trials show Novartis' Jetrea improves vitreomacular traction

17 August 2012

FDA advisory panel backs approval of ThromboGenics' ocriplasmin for VMA

29 July 2012

News briefs: Priority review for ocriplasmin; Zonegran monotherapy in EU

3 July 2012

ThromboGenics re-files ocriplasmin BLA and Inspiration submits IB 1001 to FDA

17 April 2012

Novartis unit buys rights to ThromboGenics eye drug

16 March 2012

ThromboGenics confident as it plans for ocriplasmin launch

12 March 2012

Positive new Ph III data on ThromboGenics’ ocriplasmin

22 August 2011

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end